C07F 9/5435
Cycloaliphatic phosphonium compounds
Official title: {Cycloaliphatic phosphonium compounds}
C07F9/5435 (Cycloaliphatic phosphonium compounds) appears on 55 US grants and 25 published applications in this corpus.
Search patents in C07F- Granted patents
- 55
- Published applications
- 25
- Assignees
- 34
- Inventors
- 119
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 2 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 2 | 0 |
| 2014 | 3 | 3 |
| 2015 | 1 | 2 |
| 2016 | 2 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 2 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug7 Apr 2026US 12,594,283 B2Aix-Marseille Universite
- Azithromycin derivatives containing a phosphonium ion as anticancer agents30 Aug 2022US 11,427,606 B2
- Zwitterion-ruthenium complex for catalytic aerobic oxidation reactions12 Apr 2022US 11,298,694 B2The Chinese University of Hong Kong
- Phosphonium-ion tethered tetracycline drugs for treatment of cancer2 Nov 2021US 11,161,862 B2Oxford University Innovation Limited
- Oral formulations of mitochondrially-targeted antioxidants and their preparation and use21 Feb 2017US 9,572,890 B2Mitotech SA
- Mitochondria-targeted atovaquone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug25 Jun 2026US 2026/0174785 A1Aix-Marseille Universite
- Phosphorus-containing passivator, perovskite solar cell, photovoltaic module, photovoltaic system, and electric apparatus29 Jan 2026US 2026/0033235 A1Contemporary Amperex Future Energy Research Institute (Shanghai) Limited
- Nicotinate and nicotinamide riboside-based compounds and derivatives thereof3 Aug 2023US 2023/0242558 A1New Frontier Bio, Inc.
- Mitochondria-Targeted Atovaqone: A More Potent and More Effective Antitumor, Antimicrobial, and Antimalarial Drug19 Jan 2023US 2023/0017373 A1Aix-Marseille Universite
- Azithromycin derivatives containing a phosphonium ion as anticancer agents19 Aug 2021US 2021/0253616 A1Rising Tide Foundation
Most cited
By later US patents
- Mercaptoacyl derivatives of various 4-substituted prolines31US 4,316,905 AE. R. Squibb & Sons, Inc. · 1982
- Ethynylcyclohexene compounds30US 4,952,716 AHoffmann-La Roche Inc. · 1990
- Ethynylcyclohexene compounds and processes for manufacture thereof25US 5,227,507 AHoffmann-La Roche Inc. · 1993
- Process for the manufacture of cyclohexene derivatives19US 4,405,417 AHoffmann-La Roche Inc. · 1983
- Process for the manufacture of cyclohexene derivatives16US 4,579,973 AHoffman-La Roche Inc. · 1986